Urothelial Cancer Overview
Learn About Urothelial Cancer
Michigan Institute Of Urology
Brian Seifman is an Urologist in Rochester Hills, Michigan. Dr. Seifman and is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Congenital Mesoblastic Nephroma, Prostate Cancer, Ureteroscopy, and Lithotripsy. Dr. Seifman is currently accepting new patients.
Michigan Institute Of Urology
Kenneth Kernen is an Urologist in Troy, Michigan. Dr. Kernen and is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Nephrectomy, and Reconstructive Urology Surgery. Dr. Kernen is currently accepting new patients.
Michigan Institute Of Urology
Jason Hafron is an Urologist in Troy, Michigan. Dr. Hafron and is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Ureteroscopy. Dr. Hafron is currently accepting new patients.
Summary: This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Summary: This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them fr...